• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经退行性痴呆中的神经软体征:DemeNSS研究结果

Neurological soft signs in neurodegenerative dementias: Results of the DemeNSS study.

作者信息

Pozzi Federico Emanuele, Falco Anna, Gotti Gaia, Fiamingo Giuseppe, Remoli Giulia, Appollonio Ildebrando, Ferrarese Carlo, Tremolizzo Lucio

机构信息

Neurology Department Fondazione IRCCS San Gerardo dei Tintori Monza Italy.

Milan Center for Neuroscience (NeuroMI) University of Milano-Bicocca Milan Italy.

出版信息

PCN Rep. 2025 Jun 25;4(2):e70143. doi: 10.1002/pcn5.70143. eCollection 2025 Jun.

DOI:10.1002/pcn5.70143
PMID:40567948
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12188626/
Abstract

AIM

Neurological soft signs (NSSs) encompass subtle neurological abnormalities, often indicative of impaired motor and sensory integration, observed in various neuropsychiatric conditions. NSSs have been recently investigated as potential diagnostic markers in neurodegenerative dementias. We aimed to confirm an NSS increase in subjects with cognitive decline and evaluate them in the differential diagnosis of neurodegenerative dementias.

METHODS

A sample of 93 subjects with dementia (34 with Alzheimer's disease [AD], 29 with frontotemporal dementia [FTD], 16 with Lewy body disease [LBD], and 14 with corticobasal syndrome [CBS]) and 93 healthy controls (HCs) were assessed using the 16-item Heidelberg NSS Scale.

RESULTS

Subjects with neurodegenerative dementias exhibited significantly higher NSS scores than HCs (20.4 ± 7.9 vs. 5.7 ± 4.2,  < 0.01). Notably, those with CBS/LBD showed markedly elevated NSSs compared to those with AD and FTD (26.2 ± 6.7 vs. 18.4 ± 7.1 and 16.6 ± 6.5, respectively,  < 0.01). Diagnosis, Mini-Mental State Examination (MMSE), Frontal Assessment Battery, and anticholinergic burden were significant predictors of NSS expression in subjects with dementia. In HCs, only age and MMSE were significant predictors. A reduced Neurological Soft Signs (rNSS) Scale, including only five items that can be administered in less than a minute, demonstrated diagnostic performances comparable to the full NSS Scale.

CONCLUSION

NSSs are increased across neurodegenerative dementia subtypes, particularly in CBS and LBD. The Heidelberg NSS Scale, as well as its variant rNSS, may serve as quick and informative tools to be added to the visits in memory clinics.

摘要

目的

神经软体征(NSSs)包括在各种神经精神疾病中观察到的细微神经异常,常提示运动和感觉整合受损。最近,NSSs已被作为神经退行性痴呆的潜在诊断标志物进行研究。我们旨在证实认知功能下降患者的NSS增加,并在神经退行性痴呆的鉴别诊断中对其进行评估。

方法

使用16项海德堡NSS量表对93例痴呆患者(34例阿尔茨海默病[AD]、29例额颞叶痴呆[FTD]、16例路易体病[LBD]和14例皮质基底节综合征[CBS])和93例健康对照(HCs)进行评估。

结果

神经退行性痴呆患者的NSS评分显著高于HCs(20.4±7.9对5.7±4.2,<0.01)。值得注意的是,与AD和FTD患者相比,CBS/LBD患者的NSS显著升高(分别为26.2±6.7对18.4±7.1和16.6±6.5,<0.01)。诊断、简易精神状态检查表(MMSE)、额叶评估量表和抗胆碱能负担是痴呆患者NSS表达的重要预测因素。在HCs中,只有年龄和MMSE是重要预测因素。简化神经软体征(rNSS)量表仅包括5项可在不到1分钟内完成的项目,其诊断性能与完整的NSS量表相当。

结论

神经退行性痴呆各亚型的NSS均升高,尤其是CBS和LBD。海德堡NSS量表及其变体rNSS可作为记忆门诊就诊时快速且提供信息的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90b8/12188626/37209ab92912/PCN5-4-e70143-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90b8/12188626/05a02ec0a807/PCN5-4-e70143-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90b8/12188626/0ccf6ee2e14b/PCN5-4-e70143-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90b8/12188626/37209ab92912/PCN5-4-e70143-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90b8/12188626/05a02ec0a807/PCN5-4-e70143-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90b8/12188626/0ccf6ee2e14b/PCN5-4-e70143-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90b8/12188626/37209ab92912/PCN5-4-e70143-g003.jpg

相似文献

1
Neurological soft signs in neurodegenerative dementias: Results of the DemeNSS study.神经退行性痴呆中的神经软体征:DemeNSS研究结果
PCN Rep. 2025 Jun 25;4(2):e70143. doi: 10.1002/pcn5.70143. eCollection 2025 Jun.
2
Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia.抗胆碱能负担预测轻度认知障碍或痴呆老年患者认知下降或神经精神症状。
Cochrane Database Syst Rev. 2022 Aug 22;8(8):CD015196. doi: 10.1002/14651858.CD015196.pub2.
3
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
4
Folic acid with or without vitamin B12 for cognition and dementia.叶酸联合或不联合维生素B12对认知及痴呆的影响
Cochrane Database Syst Rev. 2003(4):CD004514. doi: 10.1002/14651858.CD004514.
5
18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代硼吡咯进行18F正电子发射断层显像以早期诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012216. doi: 10.1002/14651858.CD012216.pub2.
6
Donepezil for dementia due to Alzheimer's disease.多奈哌齐用于治疗阿尔茨海默病所致的痴呆。
Cochrane Database Syst Rev. 2018 Jun 18;6(6):CD001190. doi: 10.1002/14651858.CD001190.pub3.
7
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.用于路易体痴呆、帕金森病痴呆及帕金森病认知障碍的胆碱酯酶抑制剂
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD006504. doi: 10.1002/14651858.CD006504.pub2.
8
Galantamine for Alzheimer's disease.加兰他敏用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2002(3):CD001747. doi: 10.1002/14651858.CD001747.
9
Metal protein attenuating compounds for the treatment of Alzheimer's dementia.用于治疗阿尔茨海默病痴呆症的金属蛋白衰减化合物。
Cochrane Database Syst Rev. 2012 May 16;5(5):CD005380. doi: 10.1002/14651858.CD005380.pub4.
10
Hormone replacement therapy to maintain cognitive function in women with dementia.激素替代疗法用于维持痴呆女性的认知功能。
Cochrane Database Syst Rev. 2002(3):CD003799. doi: 10.1002/14651858.CD003799.

本文引用的文献

1
Increased anticholinergic medication use in middle-aged and older autistic adults and its associations with self-reported memory difficulties and cognitive decline.中年和老年自闭症成年人中抗胆碱能药物使用的增加及其与自我报告的记忆困难和认知能力下降的关系。
Autism Res. 2024 Apr;17(4):852-867. doi: 10.1002/aur.3076. Epub 2023 Dec 18.
2
Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia.小脑和皮质下萎缩导致额颞叶痴呆的精神症状。
Hum Brain Mapp. 2023 May;44(7):2684-2700. doi: 10.1002/hbm.26220. Epub 2023 Mar 9.
3
Functional correlates of neurological soft signs in heavy cannabis users.
重度大麻使用者神经软体征的功能相关性
Addict Biol. 2023 Mar;28(3):e13270. doi: 10.1111/adb.13270.
4
Neurological soft signs are increased in major depressive disorder irrespective of treatment.神经软体征在重度抑郁症中增加,与治疗无关。
J Neural Transm (Vienna). 2023 Apr;130(4):575-583. doi: 10.1007/s00702-023-02602-z. Epub 2023 Feb 20.
5
Anticholinergic Drug Burden and Risk of Incident MCI and Dementia: A Population-based Study.抗胆碱能药物负担与轻度认知障碍和痴呆症发病风险:一项基于人群的研究。
Alzheimer Dis Assoc Disord. 2023;37(1):20-27. doi: 10.1097/WAD.0000000000000538. Epub 2023 Jan 18.
6
Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia.抗精神病药和抗胆碱能药物对慢性精神分裂症患者认知功能的影响。
BMC Psychiatry. 2023 Jan 24;23(1):61. doi: 10.1186/s12888-023-04552-y.
7
The Impact of Antipsychotic Treatment on Neurological Soft Signs in Patients with Predominantly Negative Symptoms of Schizophrenia.抗精神病药物治疗对以精神分裂症阴性症状为主的患者神经软体征的影响
Biomedicines. 2022 Nov 15;10(11):2939. doi: 10.3390/biomedicines10112939.
8
Predictors of response to acetylcholinesterase inhibitors in dementia: A systematic review.痴呆症中对乙酰胆碱酯酶抑制剂反应的预测因素:一项系统评价。
Front Neurosci. 2022 Sep 20;16:998224. doi: 10.3389/fnins.2022.998224. eCollection 2022.
9
Evidence of cerebellar TDP-43 loss of function in FTLD-TDP.在 FTLD-TDP 中发现小脑 TDP-43 功能丧失的证据。
Acta Neuropathol Commun. 2022 Jul 25;10(1):107. doi: 10.1186/s40478-022-01408-6.
10
Anticholinergic burden and cognitive performance: cross-sectional results from the ELSA-Brasil study.抗胆碱能负担与认知表现:来自 ELSA-Brasil 研究的横断面结果。
Eur J Clin Pharmacol. 2022 Sep;78(9):1527-1534. doi: 10.1007/s00228-022-03361-8. Epub 2022 Jun 28.